Abstract:Phosphoglucose isomerase/autocrine motility factor (PGI/AMF), a housekeeping gene product that plays a key role in both glycolysis and gluconeogenesis pathways, is associated with invasion and metastasis of cancer cells. PGI/AMF is involved in the induction of Epithelial-to-Mesenchymal transition (EMT) phenotype in breast cancer cells, which leads to increased aggressiveness; however, the molecular mechanism by which PGI/AMF regulates EMT is not known. Here, we show, for the first time, that the over-expression of PGI/AMF leads to an increase in the DNA-binding activity of NF-κB, which in turn causes increased expression of ZEB1/ZEB2. Since microRNA-200s (miR-200s; miR-200a, miR-200b and miR-200c) are known to negatively regulate the expression of ZEB1/ZEB2, we assessed their expression and found that the expression of miR-200s was lost in PGI/AMF over-expressing MCF-10A cells as well as in highly invasive MDA-MB-231 cells, which was consistent with increased expression of ZEB1/ZEB2. Moreover, silencing of PGI/AMF expression in MDA-MB-231 cells led to re-expression of miR-200s, which was associated with the reversal of EMT phenotype i.e. Mesenchymal-to-Epithelial Transition (MET), and these findings were consistent with alterations in the relative expression of epithelial (E-cadherin) and mesenchymal (vimentin, ZEB1, ZEB2) markers, and decreased aggressiveness, as judged by clonogenic, motility and invasion assays. Silencing of PGI/AMF was also found to result in significantly reduced pulmonary metastases in vivo. Collectively, these results suggest, for the first time, the role of miR-200s in PGI/AMF induced EMT-MET, and thus clinical approaches for up-regulation of miR-200s could become a novel therapeutic strategy for the treatment of highly invasive breast cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 3361. doi:10.1158/1538-7445.AM2011-3361

The Mir-200 Family Regulates The Epithelial-Mesenchymal Transition Induced By Egf/Egfr In Anaplastic Thyroid Cancer Cells

Transcriptional Repression of Mir-200 Family Members by Nanog in Colon Cancer Cells Induces Epithelial Mesenchymal Transition (Emt)

MicroRNA-200 (miR-200) Cluster Regulation by Achaete Scute-like 2 (Ascl2): IMPACT ON THE EPITHELIAL-MESENCHYMAL TRANSITION IN COLON CANCER CELLS

Mir-200C Overexpression is Associated with Better Efficacy of EGFR-TKIs in Non-Small Cell Lung Cancer Patients with EGFR Wild-Type.

Abstract 3361: Phosphoglucose Isomerase/autocrine Motility Factor Mediates Epithelial-Mesenchymal Transition Regulated by Mir-200 in Breast Cancer Cells

Mir-106B Promotes Cell Invasion and Metastasis Via PTEN Mediated EMT in ESCC.

Downregulated Microrna-200a Promotes Emt And Tumor Growth Through The Wnt/Beta-Catenin Pathway By Targeting The E-Cadherin Repressors Zeb1/Zeb2 In Gastric Adenocarcinoma

P-Akt/miR‑200 Signaling Regulates Epithelial-Mesenchymal Transition, Migration and Invasion in Circulating Gastric Tumor Cells.

MiR-146b-5p Promotes Metastasis and Induces Epithelial-Mesenchymal Transition in Thyroid Cancer by Targeting ZNRF3.

The EGFR/miR-338-3p/EYA2 axis controls breast tumor growth and lung metastasis.

miR-200a-3p promotes the malignancy of endometrial carcinoma through negative regulation of epithelial-mesenchymal transition

Tamoxifen Represses Mir-200 Micrornas and Promotes Epithelial-to-mesenchymal Transition by Up-Regulating C-Myc in Endometrial Carcinoma Cell Lines.

MicroRNAs Provide Feedback Regulation of Epithelial‐Mesenchymal Transition Induced by Growth Factors

MicroRNA-200a Inhibits the Process of Epithelial-Mesenchymal Transition in Gastric Carcinoma

Mir-153-3p Suppresses Cell Proliferation, Invasion And Glycolysis Of Thyroid Cancer Through Inhibiting E3f3 Expression

MicroRNA-625-3p Promotes the Proliferation, Migration and Invasion of Thyroid Cancer Cells by Up-Regulating Astrocyte Elevated Gene 1.

The Role of MicroRNA in the Regulation of Tumor Epithelial–Mesenchymal Transition

Downregulation of Mir‐3127‐5p Promotes Epithelial‐mesenchymal Transition Via FZD4 Regulation of Wnt/β‐catenin Signaling in Non‐small‐cell Lung Cancer

Interleukin-8 Promotes Epithelial-to-Mesenchymal Transition Via Downregulation of Mir-200 Family in Breast Cancer Cells

Epidermal Growth Factor-Induced C/EBPbeta Participates in EMT by Dampening Mir-203 in Esophageal Squamous Cell Carcinoma

Exosome-mediated miR-200a delivery into TGF-β-treated AGS cells abolished epithelial-mesenchymal transition with normalization of ZEB1, vimentin and Snail1 expression